Ionis Pharmaceuticals to acquire remaining stake in Akcea Therapeutics

Source - MicroSmallCap

– Ionis to acquire remaining 24% of common stock of Akcea it does not already own for $18.15 per share in cash – Transaction drives efficiencies, enhances capabilities and further strengthens Ionis’ financial position – Transaction is a key step in the evolution of Ionis’ business strategy

CARLSBAD, Calif. and BOSTON, Aug. 31, 2020 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) and its affiliate Akcea Therapeutics, Inc. (NASDAQ: AKCA) today announced that they have entered into a definitive agreement under which Ionis will acquire all of the outstanding shares of Akcea common stock it does not already own, approximately 24%, ...

Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.

All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.

Share this post

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email